Google is stepping up its presence in India’s healthcare sector by partnering with Apollo Radiology International (ARI) to bring artificial intelligence (AI) into the early detection of critical diseases like tuberculosis, breast cancer, and lung cancer. This collaboration aims to bridge the gap in healthcare quality and accessibility.
What Happened: At the global Google Health Check-up event, Google Health and the Apollo Group revealed they have engineered AI models to enhance radiology and diagnosis. These advanced AI systems are now aiding radiologists in analyzing chest X-rays for TB, spotting incidental nodules in cancer patients, and interpreting mammograms — tasks that demand high specialization and expertise.
Shravya Shetty, a leading figure at Google Research, announced that over the next decade, ARI will roll out three million free AI-powered screenings for these diseases. This initiative aims not only to make screenings widely available but also to add an extra layer of analysis to ensure nothing gets missed.
See also: Zomato Buckles To Online Backlash, Scraps Green Uniforms For ‘Pure Veg’ Orders
Not Google’s first rodeo with Apollo: Google’s collaboration with Apollo isn’t new. They’ve been validating these AI systems in areas with the most significant need. Now, they are actively working to secure the necessary regulatory approvals to integrate these models into clinical care across India, underscoring the crucial role of AI amid a shortage of skilled radiologists in the densely populated nation.
This AI venture tackles a harsh reality: TB infects millions annually, resulting in a high mortality rate in regions such as South Asia and Sub-Saharan Africa. Moreover, India battles grimly against breast cancer, with its death rates significantly surpassing those in the US.
Read next: Amazon Plans To Release More Than 70 Originals To Outpace Netflix, Disney-Reliance
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.